This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
After Plunging -11.42% in 4 Weeks, Here's Why the Trend Might Reverse for Global Medical REIT (GMRE)
by Zacks Equity Research
Global Medical REIT (GMRE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Global Medical REIT (GMRE) Misses Q4 FFO and Revenue Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -4.17% and 8.02%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Insights Into Global Medical REIT (GMRE) Q4: Wall Street Projections for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Global Medical REIT (GMRE) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
City Office REIT (CIO) Q4 FFO Meet Estimates
by Zacks Equity Research
City Office REIT (CIO) delivered FFO and revenue surprises of 0% and 0.34%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Global Medical REIT (GMRE) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
Plymouth Industrial (PLYM) Meets Q3 FFO Estimates
by Zacks Equity Research
Plymouth Industrial (PLYM) delivered FFO and revenue surprises of 0% and 1.62%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
CTO Realty (CTO) Q3 FFO and Revenues Beat Estimates
by Zacks Equity Research
CTO Realty (CTO) delivered FFO and revenue surprises of 20% and 11.60%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Global Medical REIT (GMRE) Misses Q2 FFO and Revenue Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -8% and 1.89%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Alexander & Baldwin Holdings, Inc. (ALEX) Lags Q2 FFO Estimates
by Zacks Equity Research
Alexander & Baldwin Holdings, Inc. (ALEX) delivered FFO and revenue surprises of -3.33% and 8.59%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Global Medical REIT (GMRE) Misses Q1 FFO and Revenue Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -8% and 0.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Healthpeak (PEAK) Q1 FFO Meet Estimates
by Zacks Equity Research
Healthpeak (PEAK) delivered FFO and revenue surprises of 0% and 1.73%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Is the Options Market Predicting a Spike in Global Medical REIT (GMRE) Stock?
by Zacks Equity Research
Investors need to pay close attention to Global Medical REIT (GMRE) stock based on the movements in the options market lately.
Plymouth Industrial (PLYM) Q4 FFO and Revenues Lag Estimates
by Zacks Equity Research
Plymouth Industrial (PLYM) delivered FFO and revenue surprises of -2.22% and 3.13%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Life Storage (LSI) Stock Jumps 11.3%: Will It Continue to Soar?
by Zacks Equity Research
Life Storage (LSI) witnessed a jump in share price last session on above-average trading volume. The latest trend in FFO estimate revisions for the stock suggests that there could be more strength down the road.
Global Medical REIT (GMRE) Q3 FFO Lag Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -3.85% and 2.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
GMRE or CUBE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GMRE vs. CUBE: Which Stock Is the Better Value Option?
Global Medical REIT (GMRE) Q2 FFO Miss Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -3.85% and 5.91%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Summit Hotel Properties (INN) Misses Q2 FFO Estimates
by Zacks Equity Research
Summit Hotel Properties (INN) delivered FFO and revenue surprises of -6.90% and 5.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Douglas Emmett (DEI) Meets Q2 FFO Estimates
by Zacks Equity Research
Douglas Emmett (DEI) delivered FFO and revenue surprises of 0% and 2.17%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Corporate Office Properties (OFC) Tops Q2 FFO and Revenue Estimates
by Zacks Equity Research
Corporate Office Properties (OFC) delivered FFO and revenue surprises of 1.72% and 3.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
SL Green (SLG) Q2 FFO Surpass Estimates
by Zacks Equity Research
SL Green (SLG) delivered FFO and revenue surprises of 10.65% and 2%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Sunstone Hotel (SHO) Moves 8.4% Higher: Will This Strength Last?
by Zacks Equity Research
Sunstone Hotel (SHO) witnessed a jump in share price last session on above-average trading volume. The latest trend in FFO estimate revisions for the stock doesn't suggest further strength down the road.
Global Medical REIT (GMRE) Q1 FFO Lag Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -7.69% and 4.03%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Community Healthcare Trust (CHCT) Beats Q1 FFO Estimates
by Zacks Equity Research
Community Healthcare Trust (CHCT) delivered FFO and revenue surprises of 3.39% and 1.96%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Global Medical REIT (GMRE) Meets Q4 FFO Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0% and 0.94%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?